Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

yf_tkr_WFC · 2026-08-24

$ELTX $WFC

BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that management will participate in one-on-one meetings at the upcoming Wells Fargo 21st Annual Healthcare Conference, taking place September 8-10, 2026, in Boston, MA. Wells Fargo 21st Annual Healthcare ConferenceFormat: One-on-one MeetingsDate: Thursday, September

Read the original at yf_tkr_WFC ↗

Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.